givosiran
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for givosiran, covering 2020-02-11 to 2024-03-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP) [Phase 1, Phase 2]